Related Experiment Video

Updated: Mar 24, 2026

Unilateral Ureteral Obstruction Model for Investigating Kidney Interstitial Fibrosis
04:37

Unilateral Ureteral Obstruction Model for Investigating Kidney Interstitial Fibrosis

Published on: April 25, 2025

1.8K

[Mechanism of and Therapy for Kidney Fibrosis]

Akihiro Kuma1, Masahito Tamura, Yutaka Otsuji

  • 1Second Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan.

Journal of UOEH
|March 15, 2016
PubMed

Insights

Kidney fibrosis involves specific cellular mechanisms and pathways, distinct from other organs. Understanding these unique processes is crucial for developing targeted therapies to combat kidney scarring and dysfunction.

Area of Science:

  • Nephrology
  • Pathology
  • Cell Biology

Background:

  • Kidney fibrosis, a scarring process, impairs kidney function and can lead to chronic kidney disease.
  • Advanced fibrosis necessitates dialysis or transplantation due to irreversible tissue damage.
  • Elucidating kidney fibrosis mechanisms is vital for therapeutic development.

Purpose of the Study:

  • To review the specific cellular and molecular mechanisms underlying kidney fibrosis.
  • To highlight pathways unique to kidney fibrosis, differentiating it from fibrosis in other organs.
  • To discuss potential therapeutic strategies targeting these mechanisms.

Main Methods:

  • Literature review focusing on cellular and molecular pathways in kidney fibrosis.
  • Analysis of specific kidney cell types involved in fibrosis.
  • Examination of key signaling pathways like TGF-β and WNT.

Main Results:

  • Kidney fibrosis involves unique cell types (tubular epithelial, mesangial, erythropoietin-producing cells) and pathways.
  • Transforming growth factor-β (TGF-β) signaling, epithelial-mesenchymal transition, WNT signaling, renal anemia, and uremia are key factors.
  • Common fibrotic mechanisms like fibroblast activation are also relevant.

Conclusions:

  • Targeting kidney-specific mechanisms offers promising therapeutic avenues.
  • Potential therapies include anti-TGF-β antibodies and mTOR inhibitors.
  • Further research into these specific pathways can improve treatment outcomes for kidney fibrosis.

More Related Videos

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection10:15

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection

Published on: November 10, 2021

2.3K
Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

1.1K

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.4K
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
595
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
455
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.1K
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
751
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
469